NAD+ Research Guide: Cellular Energy, Ageing, and Longevity

NAD+ (nicotinamide adenine dinucleotide) is not a peptide in the traditional sense, but it has become one of the most intensely researched molecules in cellular biology. Interest in NAD+ has grown rapidly because of its central role in mitochondrial energy production, DNA repair, sirtuin activation, and cellular ageing processes. ^[1]

This guide is aimed at researchers who want to understand what the current published evidence actually shows without the hype that tends to surround longevity-related compounds.

What Is NAD+?

NAD+ is a coenzyme found in every living cell. It exists in two main forms: NAD+ (oxidised) and NADH (reduced). The ratio between them is central to cellular redox balance, the exchange of electrons that drives mitochondrial ATP production, the core energy currency of all biological processes.

Beyond energy metabolism, NAD+ acts as a substrate for a class of enzymes called sirtuins (SIRT1-SIRT7), which are involved in gene expression regulation, DNA damage repair, inflammation control, and metabolic adaptation. Sirtuins cannot function without NAD+, which is why declining NAD+ levels with age have attracted so much research attention. They directly constrain sirtuin activity. ^[2]

Why NAD+ Declines with Age

Research has established that NAD+ levels decline substantially across tissues in ageing organisms, including in humans. Several mechanisms have been proposed: increased consumption by CD38 (an NAD+-degrading enzyme that becomes more active with age), reduced biosynthesis from dietary precursors, and increased demand from DNA repair enzymes (PARPs) responding to age-related DNA damage accumulation. ^[3]

The consequence is a compound effect: as NAD+ falls, sirtuin activity drops, mitochondrial efficiency decreases, DNA repair becomes less effective, and inflammatory signalling becomes dysregulated. This cascade is a major reason NAD+ supplementation and precursor research has been a focus of longevity biology labs for the past decade.

NAD+ Precursors: NMN and NR

Because direct NAD+ supplementation faces bioavailability challenges (the molecule is too large to cross cell membranes efficiently), research has focused on NAD+ precursors, compounds that cells can use to synthesise NAD+ internally. The two most studied are:

• NMN (nicotinamide mononucleotide) — converted to NAD+ via the Slc12a8 transporter in mice and possibly other routes in human tissue
• NR (nicotinamide riboside) — converted first to NMN, then to NAD+, raising intracellular NAD+ in both animal models and human trials

A landmark human study published in Science (2021) found that NMN supplementation increased muscle NAD+ levels and improved insulin sensitivity in postmenopausal women with prediabetes, one of the first robust human trials to show metabolic effects from an NAD+ precursor. ^[4]

NAD+ and Mitochondrial Function

The mitochondrial angle is where NAD+ research intersects most clearly with the cellular energy narrative. In the electron transport chain, NADH donates electrons to Complex I, initiating the cascade that drives ATP synthase. When NAD+ is depleted, this pathway is constrained, cells produce less ATP and become less efficient at handling metabolic demand.

Animal research has shown that restoring NAD+ levels in aged mice can improve mitochondrial function, increase muscle endurance, and in some models, improve healthy lifespan markers. These findings have driven interest in whether similar effects can be demonstrated in human physiology. ^[1]

NAD+ and DNA Repair

One of the most compelling aspects of NAD+ biology is its role in DNA repair. PARP enzymes (poly ADP-ribose polymerases), which are critical for repairing single-strand DNA breaks, consume NAD+ as a substrate. When DNA damage is high, as it is in ageing tissues, oxidative stress conditions, or UV-exposed cells, PARP activity rises, consuming NAD+ faster than it can be replenished.

This creates a feedback loop: low NAD+ leads to reduced sirtuin activity, reduced DNA repair coordination, more damage, more PARP activation, and further NAD+ depletion. Interrupting this cycle is one rationale for studying NAD+ precursor supplementation in the context of cellular resilience and ageing biology.

What Australian Researchers Are Looking At

In Australia, NAD+ research typically intersects with:

• Cellular ageing and longevity biology — sirtuin activation, mitochondrial efficiency, healthspan markers
• Metabolic research — insulin sensitivity, glucose metabolism, energy expenditure in muscle tissue
• Neuroprotection — NAD+ roles in neuronal energy supply and DNA repair under stress conditions
• Inflammation and immune function — CD38 biology, inflammatory cytokine regulation in aged tissue models

Bottom Line

NAD+ sits at the intersection of energy metabolism, DNA repair, sirtuin biology, and cellular ageing, a convergence that explains why it has attracted serious attention from researchers across multiple fields. The animal data is compelling. The early human trials are promising. The key research agenda now is establishing which populations, doses, and delivery approaches produce meaningful effects in human tissue, and what the full downstream consequences of sustained NAD+ augmentation look like in ageing biology.

References

1. Rajman L, Chwalek K, Sinclair DA. Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence. Cell Metab. 2018.
2. Canto C, Menzies KJ, Auwerx J. NAD(+) Metabolism and Its Roles in Cellular Processes during Ageing. Cell Metab. 2015.
3. Verdin E. NAD+ in aging, metabolism, and neurodegeneration. Science. 2015.
4. Yoshino M et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021.

⚠ All information is for educational and research purposes only. NAD+ supplied by Aussie Peptides is for in-vitro laboratory research only and not for human consumption.